Privia Health (PRVA) Capital Expenditures (2020 - 2026)

Privia Health's Capital Expenditures history runs 7 years deep, the most recent figure standing at -$978000.0 for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 255.64% year-over-year to -$978000.0 in Q1 2026; TTM through Mar 2026 was -$377000.0, a 401.6% decrease from a year earlier, with the FY2025 full-year figure at $326000.0, down 81.06% from the prior year.
• Capital Expenditures fell to -$978000.0 in Q1 2026 per PRVA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $7.6 million in Q3 2022 and bottomed at -$9.1 million in Q4 2022.
• The 5-year median for Capital Expenditures is $20000.0 (2023), against an average of $123764.7.
• Across the five-year window, Capital Expenditures soared 3774.11% in 2022 and slumped 3325.0% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at -$9.1 million in 2022, then soared by 112.9% to $1.2 million in 2023, then surged by 40.87% to $1.7 million in 2024, then jumped by 61.78% to $2.7 million in 2025, then sank by 136.62% to -$978000.0 in 2026.
• Per Business Quant, the three latest PRVA Capital Expenditures figures stand at -$978000.0 (Q1 2026), $2.7 million (Q4 2025), and -$1.3 million (Q3 2025).